Back
Alibaba Health Information Technology Ltd. 10K Form
Sell
23
ALBBY
Alibaba Health Information Technology Ltd.
Last Price:
$13.14
Seasonality Move:
7.73%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ALBBY News And Ratings
See the #1 stock for the next 7 days that we like better than ALBBY
ALBBY Financial Statistics
Sales & Book Value
| Annual Sales: | $4.2B |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 42.48 |
| Annual Sales: | $2.79 |
| Price / Book: | 4.48 |
Profitability
| EPS (TTM): | 0.33070 |
|---|---|
| Net Income (TTM): | $267.7M |
| Gross Margin: | $1B |
| Return on Equity: | 9.22% |
| Return on Assets: | 6.95% |
Alibaba Health Information Technology Ltd. Earnings Forecast
Key Alibaba Health Information Technology Ltd. Financial Ratios
-
The Gross Profit Margin over the past 22 years for ALBBY is 24.23%.
-
The Selling, General & Administrative Expenses for ALBBY have been equal to 8.71% of Gross Profit Margin.
-
The Research & Development expenses have been 2.35% of Revenue.
-
The Interest Expense is 0.18% of Operating Income.
-
The Net Earning history of ALBBY is 4.68% of Total Revenues.
-
Per Share Earnings over the last 22 years have been positive in 13 years.
Alibaba Health Information Technology Ltd. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Consumer Staples Distribution & Retail |
| Sector: | Consumer Staples |
| Current Symbol: | ALBBY |
| Website: | alihealth.cn |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 2.59 |
| Quick Ratio: | 2.22 |
Price-to-Earnings
| Trailing P/E Ratio: | 53.41 |
|---|---|
| Forward P/E Ratio: | 0 |
ALBBY Technical Analysis vs Fundamental Analysis
Sell
23
Alibaba Health Information Technology Ltd. (ALBBY)
is a Sell
Is Alibaba Health Information Technology Ltd. a Buy or a Sell?
-
Alibaba Health Information Technology Ltd. stock is rated a SellThe current Alibaba Health Information Technology Ltd. [ALBBY] share price is $13.14. The Score for ALBBY is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.